FI57408C - Foerfarande foer framstaellning av antiallergiska 3-(tetrazol-5-yl)-kromoner - Google Patents
Foerfarande foer framstaellning av antiallergiska 3-(tetrazol-5-yl)-kromoner Download PDFInfo
- Publication number
- FI57408C FI57408C FI1160/73A FI116073A FI57408C FI 57408 C FI57408 C FI 57408C FI 1160/73 A FI1160/73 A FI 1160/73A FI 116073 A FI116073 A FI 116073A FI 57408 C FI57408 C FI 57408C
- Authority
- FI
- Finland
- Prior art keywords
- parts
- tetrazol
- added
- mixture
- tetrahydrofuran
- Prior art date
Links
- 230000003266 anti-allergic effect Effects 0.000 title claims description 7
- -1 TETRAZOLE-5-YL Chemical class 0.000 title description 26
- 238000005057 refrigeration Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 claims description 49
- 238000002844 melting Methods 0.000 claims description 25
- 230000008018 melting Effects 0.000 claims description 25
- 150000001875 compounds Chemical class 0.000 claims description 22
- 150000003839 salts Chemical class 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 11
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 9
- HJOBCUUZGWRLTO-UHFFFAOYSA-N 3-(2h-tetrazol-5-yl)chromen-4-one Chemical class C=1OC2=CC=CC=C2C(=O)C=1C=1N=NNN=1 HJOBCUUZGWRLTO-UHFFFAOYSA-N 0.000 claims description 7
- 229910017604 nitric acid Inorganic materials 0.000 claims description 7
- 125000003545 alkoxy group Chemical group 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 2
- 125000003277 amino group Chemical group 0.000 claims description 2
- 125000006165 cyclic alkyl group Chemical group 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims 3
- KBGGLVWRGYLXRF-UHFFFAOYSA-N 8-methoxy-3-(2h-tetrazol-5-yl)chromen-4-one Chemical compound COC1=CC=CC(C2=O)=C1OC=C2C1=NN=NN1 KBGGLVWRGYLXRF-UHFFFAOYSA-N 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 150000001721 carbon Chemical group 0.000 claims 1
- 238000000354 decomposition reaction Methods 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 76
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 50
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 50
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 38
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 28
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 28
- 238000001914 filtration Methods 0.000 description 21
- 239000007787 solid Substances 0.000 description 18
- 238000001953 recrystallisation Methods 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- UBEONZHRYRTJFN-UHFFFAOYSA-N 6-ethyl-3-(2h-tetrazol-5-yl)chromen-4-one Chemical group O=C1C2=CC(CC)=CC=C2OC=C1C=1N=NNN=1 UBEONZHRYRTJFN-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 241000700159 Rattus Species 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000005587 bubbling Effects 0.000 description 5
- WHQSYGRFZMUQGQ-UHFFFAOYSA-N n,n-dimethylformamide;hydrate Chemical compound O.CN(C)C=O WHQSYGRFZMUQGQ-UHFFFAOYSA-N 0.000 description 5
- 208000026935 allergic disease Diseases 0.000 description 4
- 229960001340 histamine Drugs 0.000 description 4
- WWECJGLXBSQKRF-UHFFFAOYSA-N n,n-dimethylformamide;methanol Chemical compound OC.CN(C)C=O WWECJGLXBSQKRF-UHFFFAOYSA-N 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- DBDBKFDJVCLVJS-UHFFFAOYSA-N 6,8-dimethyl-3-(2h-tetrazol-5-yl)chromen-4-one Chemical compound O=C1C2=CC(C)=CC(C)=C2OC=C1C1=NN=NN1 DBDBKFDJVCLVJS-UHFFFAOYSA-N 0.000 description 3
- SHYUITMLENOEDS-UHFFFAOYSA-N 6-methoxy-3-(2h-tetrazol-5-yl)chromen-4-one Chemical compound O=C1C2=CC(OC)=CC=C2OC=C1C1=NN=NN1 SHYUITMLENOEDS-UHFFFAOYSA-N 0.000 description 3
- 206010002198 Anaphylactic reaction Diseases 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000036783 anaphylactic response Effects 0.000 description 3
- 208000003455 anaphylaxis Diseases 0.000 description 3
- 239000000739 antihistaminic agent Substances 0.000 description 3
- 229940125715 antihistaminic agent Drugs 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- HNPPKZRZKDKXDO-UHFFFAOYSA-N n,n-dimethylformamide;propan-2-one Chemical compound CC(C)=O.CN(C)C=O HNPPKZRZKDKXDO-UHFFFAOYSA-N 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- IYWKFNQGONTONW-UHFFFAOYSA-N 6-(dimethylamino)-3-(2h-tetrazol-5-yl)chromen-4-one Chemical compound O=C1C2=CC(N(C)C)=CC=C2OC=C1C1=NN=NN1 IYWKFNQGONTONW-UHFFFAOYSA-N 0.000 description 2
- PVICPKVQNLKWHG-UHFFFAOYSA-N 6-ethyl-3-(2h-tetrazol-5-yl)chromen-4-one;sodium Chemical compound [Na].O=C1C2=CC(CC)=CC=C2OC=C1C=1N=NNN=1 PVICPKVQNLKWHG-UHFFFAOYSA-N 0.000 description 2
- YNZNWVPEGMADLF-UHFFFAOYSA-N 6-hydroxy-3-(2h-tetrazol-5-yl)chromen-4-one Chemical compound O=C1C2=CC(O)=CC=C2OC=C1C1=NN=NN1 YNZNWVPEGMADLF-UHFFFAOYSA-N 0.000 description 2
- MJDWXEBWPUPOOK-UHFFFAOYSA-N 7-butoxy-3-(2h-tetrazol-5-yl)chromen-4-one Chemical compound C=1C(OCCCC)=CC=C(C2=O)C=1OC=C2C1=NN=NN1 MJDWXEBWPUPOOK-UHFFFAOYSA-N 0.000 description 2
- VHHCUIADEKWJAU-UHFFFAOYSA-N 7-hydroxy-3-(2h-tetrazol-5-yl)chromen-4-one Chemical compound C=1C(O)=CC=C(C2=O)C=1OC=C2C1=NN=NN1 VHHCUIADEKWJAU-UHFFFAOYSA-N 0.000 description 2
- CJKKBKNPMSTYOS-UHFFFAOYSA-N 7-methoxy-3-(2H-tetrazol-5-yl)chromen-4-one Chemical compound N1N=NN=C1C1=COC2=CC(=CC=C2C1=O)OC CJKKBKNPMSTYOS-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- XYLFECVDEHFHPK-UHFFFAOYSA-N CCC(C=C1C2)=CC=C1OCC2C1=NN=NN1 Chemical compound CCC(C=C1C2)=CC=C1OCC2C1=NN=NN1 XYLFECVDEHFHPK-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 description 2
- 239000002841 Lewis acid Substances 0.000 description 2
- 108010058846 Ovalbumin Proteins 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- QFPHNMPZQGLYCV-UHFFFAOYSA-N chembl3278546 Chemical compound O=C1C=2C=C(O)C(O)=CC=2OC=C1C1=NN=NN1 QFPHNMPZQGLYCV-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 150000007517 lewis acids Chemical class 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 150000003536 tetrazoles Chemical group 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- ZZLXVXGOFGHKHP-UHFFFAOYSA-N 2-(2h-tetrazol-5-yl)chromen-4-one Chemical compound O1C2=CC=CC=C2C(=O)C=C1C=1N=NNN=1 ZZLXVXGOFGHKHP-UHFFFAOYSA-N 0.000 description 1
- YHWSXURHTCJUFC-UHFFFAOYSA-N 2-chloro-2-hydroxy-1-phenylethanone Chemical class OC(Cl)C(=O)C1=CC=CC=C1 YHWSXURHTCJUFC-UHFFFAOYSA-N 0.000 description 1
- IMVAJLIIWCJMJP-UHFFFAOYSA-N 4-oxo-6-propan-2-ylchromene-3-carbonitrile Chemical compound O1C=C(C#N)C(=O)C2=CC(C(C)C)=CC=C21 IMVAJLIIWCJMJP-UHFFFAOYSA-N 0.000 description 1
- UAQVSZRGIZWWLL-UHFFFAOYSA-N 4-oxo-6-propylchromene-3-carbonitrile Chemical compound O1C=C(C#N)C(=O)C2=CC(CCC)=CC=C21 UAQVSZRGIZWWLL-UHFFFAOYSA-N 0.000 description 1
- FSMYWBQIMDSGQP-UHFFFAOYSA-N 4-oxochromene-3-carbaldehyde Chemical compound C1=CC=C2C(=O)C(C=O)=COC2=C1 FSMYWBQIMDSGQP-UHFFFAOYSA-N 0.000 description 1
- SFWNPLLGXKJESA-UHFFFAOYSA-N 4-oxochromene-3-carbonitrile Chemical compound C1=CC=C2C(=O)C(C#N)=COC2=C1 SFWNPLLGXKJESA-UHFFFAOYSA-N 0.000 description 1
- FVABSUQONFWJOW-UHFFFAOYSA-N 6,7-dihydroxy-4-oxochromene-3-carbonitrile Chemical compound O1C=C(C#N)C(=O)C2=C1C=C(O)C(O)=C2 FVABSUQONFWJOW-UHFFFAOYSA-N 0.000 description 1
- CHVJARAANPAZMS-UHFFFAOYSA-N 6,8-dimethyl-4-oxochromene-3-carbonitrile Chemical compound O1C=C(C#N)C(=O)C2=CC(C)=CC(C)=C21 CHVJARAANPAZMS-UHFFFAOYSA-N 0.000 description 1
- QTDOWIWPPKGKKP-UHFFFAOYSA-N 6-(dimethylamino)-4-oxochromene-3-carbonitrile Chemical compound O1C=C(C#N)C(=O)C2=CC(N(C)C)=CC=C21 QTDOWIWPPKGKKP-UHFFFAOYSA-N 0.000 description 1
- OQLAJQAQEYDCQH-UHFFFAOYSA-N 6-butyl-3-(2h-tetrazol-5-yl)chromen-4-one Chemical compound O=C1C2=CC(CCCC)=CC=C2OC=C1C1=NN=NN1 OQLAJQAQEYDCQH-UHFFFAOYSA-N 0.000 description 1
- WXVLUOKHJBDAHP-UHFFFAOYSA-N 6-chloro-3-(2h-tetrazol-5-yl)chromen-4-one Chemical compound O=C1C2=CC(Cl)=CC=C2OC=C1C=1N=NNN=1 WXVLUOKHJBDAHP-UHFFFAOYSA-N 0.000 description 1
- JHWOLPAENJJAJP-UHFFFAOYSA-N 6-chloro-4-oxochromene-3-carbonitrile Chemical compound O1C=C(C#N)C(=O)C2=CC(Cl)=CC=C21 JHWOLPAENJJAJP-UHFFFAOYSA-N 0.000 description 1
- HKCIDVICIWFAGO-UHFFFAOYSA-N 6-cyclohexyl-4-oxochromene-3-carbonitrile Chemical compound C1=C2C(=O)C(C#N)=COC2=CC=C1C1CCCCC1 HKCIDVICIWFAGO-UHFFFAOYSA-N 0.000 description 1
- GRYXAOXVOYEENX-UHFFFAOYSA-N 6-ethyl-4-oxochromene-3-carbonitrile Chemical compound O1C=C(C#N)C(=O)C2=CC(CC)=CC=C21 GRYXAOXVOYEENX-UHFFFAOYSA-N 0.000 description 1
- GJHGKBNIFFGJBN-UHFFFAOYSA-N 6-hexyl-3-(2h-tetrazol-5-yl)chromen-4-one Chemical compound O=C1C2=CC(CCCCCC)=CC=C2OC=C1C1=NN=NN1 GJHGKBNIFFGJBN-UHFFFAOYSA-N 0.000 description 1
- KYODOYCCRUBKCO-UHFFFAOYSA-N 6-methoxy-4-oxochromene-3-carbonitrile Chemical compound O1C=C(C#N)C(=O)C2=CC(OC)=CC=C21 KYODOYCCRUBKCO-UHFFFAOYSA-N 0.000 description 1
- VVCVSDJCXCPMPC-UHFFFAOYSA-N 6-methyl-3-(2h-tetrazol-5-yl)chromen-4-one Chemical group O=C1C2=CC(C)=CC=C2OC=C1C=1N=NNN=1 VVCVSDJCXCPMPC-UHFFFAOYSA-N 0.000 description 1
- FNRLRLMPBIRUSQ-UHFFFAOYSA-N 6-methyl-4-oxochromene-3-carbonitrile Chemical compound O1C=C(C#N)C(=O)C2=CC(C)=CC=C21 FNRLRLMPBIRUSQ-UHFFFAOYSA-N 0.000 description 1
- IEZXNXOBTJVBJV-UHFFFAOYSA-N 6-nitro-2-(2h-tetrazol-5-yl)chromen-4-one Chemical compound C=1C(=O)C2=CC([N+](=O)[O-])=CC=C2OC=1C=1N=NNN=1 IEZXNXOBTJVBJV-UHFFFAOYSA-N 0.000 description 1
- XDGNQXLLFWQDEI-UHFFFAOYSA-N 6-nitro-3-(2h-tetrazol-5-yl)chromen-4-one Chemical group O=C1C2=CC([N+](=O)[O-])=CC=C2OC=C1C1=NN=NN1 XDGNQXLLFWQDEI-UHFFFAOYSA-N 0.000 description 1
- CRXKYEYNBPXYOP-UHFFFAOYSA-N 6-nitro-4-oxochromene-3-carbonitrile Chemical compound O1C=C(C#N)C(=O)C2=CC([N+](=O)[O-])=CC=C21 CRXKYEYNBPXYOP-UHFFFAOYSA-N 0.000 description 1
- OWGOLQNYJQWSJI-UHFFFAOYSA-N 6-propan-2-yl-3-(2h-tetrazol-5-yl)chromen-4-one Chemical compound O=C1C2=CC(C(C)C)=CC=C2OC=C1C=1N=NNN=1 OWGOLQNYJQWSJI-UHFFFAOYSA-N 0.000 description 1
- QOOHERVGXUOMQU-UHFFFAOYSA-N 7-butoxychromen-4-one Chemical compound C(CCC)OC1=CC=C2C(C=COC2=C1)=O QOOHERVGXUOMQU-UHFFFAOYSA-N 0.000 description 1
- INTWLMCUQXOHDC-UHFFFAOYSA-N 7-hydroxy-4-oxochromene-3-carbonitrile Chemical compound O1C=C(C#N)C(=O)C=2C1=CC(O)=CC=2 INTWLMCUQXOHDC-UHFFFAOYSA-N 0.000 description 1
- GKQQDLIXRFYLQD-UHFFFAOYSA-N 7-methoxy-4-oxochromene-3-carbonitrile Chemical compound O1C=C(C#N)C(=O)C=2C1=CC(OC)=CC=2 GKQQDLIXRFYLQD-UHFFFAOYSA-N 0.000 description 1
- RWYNFTSXZRBELM-UHFFFAOYSA-N 8-methoxy-4-oxochromene-3-carbonitrile Chemical compound O1C=C(C#N)C(=O)C2=C1C(OC)=CC=C2 RWYNFTSXZRBELM-UHFFFAOYSA-N 0.000 description 1
- IVRMZWNICZWHMI-UHFFFAOYSA-N Azide Chemical compound [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 1
- 241000588832 Bordetella pertussis Species 0.000 description 1
- COXVTLYNGOIATD-HVMBLDELSA-N CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O Chemical compound CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O COXVTLYNGOIATD-HVMBLDELSA-N 0.000 description 1
- ZUYHWKOJCAZEJV-UHFFFAOYSA-N CCC1=CC2=C(C=C1)OC(C(C2=O)(CCN)C3=NNN=N3)CCN Chemical class CCC1=CC2=C(C=C1)OC(C(C2=O)(CCN)C3=NNN=N3)CCN ZUYHWKOJCAZEJV-UHFFFAOYSA-N 0.000 description 1
- INKPNPKETJTBBA-UHFFFAOYSA-N CCCC1=CC2=C(C=C1)OCC(C2)C3=NNN=N3 Chemical compound CCCC1=CC2=C(C=C1)OCC(C2)C3=NNN=N3 INKPNPKETJTBBA-UHFFFAOYSA-N 0.000 description 1
- JVCURVBQFQHUCR-UHFFFAOYSA-N CCCCCCC1=CC2=C(C=C1)OC=CC2=O Chemical compound CCCCCCC1=CC2=C(C=C1)OC=CC2=O JVCURVBQFQHUCR-UHFFFAOYSA-N 0.000 description 1
- 241001239379 Calophysus macropterus Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000699662 Cricetomys gambianus Species 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 241001562081 Ikeda Species 0.000 description 1
- 241000786363 Rhampholeon spectrum Species 0.000 description 1
- 241000978776 Senegalia senegal Species 0.000 description 1
- 241001660366 Tomonotus Species 0.000 description 1
- UFLGIAIHIAPJJC-UHFFFAOYSA-N Tripelennamine Chemical compound C=1C=CC=NC=1N(CCN(C)C)CC1=CC=CC=C1 UFLGIAIHIAPJJC-UHFFFAOYSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- YDPLDMLRERBXAV-UHFFFAOYSA-N aluminum;triazide Chemical compound [Al+3].[N-]=[N+]=[N-].[N-]=[N+]=[N-].[N-]=[N+]=[N-] YDPLDMLRERBXAV-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- UUXFWHMUNNXFHD-UHFFFAOYSA-N barium azide Chemical compound [Ba+2].[N-]=[N+]=[N-].[N-]=[N+]=[N-] UUXFWHMUNNXFHD-UHFFFAOYSA-N 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- UETLMBWMVIQIGU-UHFFFAOYSA-N calcium azide Chemical compound [Ca+2].[N-]=[N+]=[N-].[N-]=[N+]=[N-] UETLMBWMVIQIGU-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- OTAFHZMPRISVEM-UHFFFAOYSA-N chromone Chemical compound C1=CC=C2C(=O)C=COC2=C1 OTAFHZMPRISVEM-UHFFFAOYSA-N 0.000 description 1
- 239000012050 conventional carrier Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 1
- HRIKRJRMQIBSTO-UHFFFAOYSA-N ethyl 3-cyano-4-oxochromene-6-carboxylate Chemical compound O1C=C(C#N)C(=O)C2=CC(C(=O)OCC)=CC=C21 HRIKRJRMQIBSTO-UHFFFAOYSA-N 0.000 description 1
- MVUXRJGLKUEIRM-UHFFFAOYSA-N ethyl 4-oxo-3-(2h-tetrazol-5-yl)chromene-6-carboxylate Chemical compound O=C1C2=CC(C(=O)OCC)=CC=C2OC=C1C1=NN=NN1 MVUXRJGLKUEIRM-UHFFFAOYSA-N 0.000 description 1
- 229960003699 evans blue Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- GUWHRJQTTVADPB-UHFFFAOYSA-N lithium azide Chemical compound [Li+].[N-]=[N+]=[N-] GUWHRJQTTVADPB-UHFFFAOYSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- TWRAJPCQPHBABR-UHFFFAOYSA-N magnesium;diazide Chemical compound [Mg+2].[N-]=[N+]=[N-].[N-]=[N+]=[N-] TWRAJPCQPHBABR-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- GRWIABMEEKERFV-UHFFFAOYSA-N methanol;oxolane Chemical compound OC.C1CCOC1 GRWIABMEEKERFV-UHFFFAOYSA-N 0.000 description 1
- 229960002221 methylephedrine Drugs 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229940066827 pertussis vaccine Drugs 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- TZLVRPLSVNESQC-UHFFFAOYSA-N potassium azide Chemical compound [K+].[N-]=[N+]=[N-] TZLVRPLSVNESQC-UHFFFAOYSA-N 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229960003910 promethazine Drugs 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 231100000121 skin sensitizing Toxicity 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 238000013222 sprague-dawley male rat Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- PDEROVFZLWBVSG-UHFFFAOYSA-N strontium;diazide Chemical compound [Sr+2].[N-]=[N+]=[N-].[N-]=[N+]=[N-] PDEROVFZLWBVSG-UHFFFAOYSA-N 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- PCTNAMGLSYHIPL-UHFFFAOYSA-N tin(4+) tetraazide Chemical compound [Sn+4].[N-]=[N+]=[N-].[N-]=[N+]=[N-].[N-]=[N+]=[N-].[N-]=[N+]=[N-] PCTNAMGLSYHIPL-UHFFFAOYSA-N 0.000 description 1
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 1
- UBKFNPJMWUJHGB-UHFFFAOYSA-N titanium(4+);tetraazide Chemical compound [Ti+4].[N-]=[N+]=[N-].[N-]=[N+]=[N-].[N-]=[N+]=[N-].[N-]=[N+]=[N-] UBKFNPJMWUJHGB-UHFFFAOYSA-N 0.000 description 1
- 229960003223 tripelennamine Drugs 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- QFDUTPNKBRXHTC-UHFFFAOYSA-N zinc diazide Chemical compound [Zn++].[N-]=[N+]=[N-].[N-]=[N+]=[N-] QFDUTPNKBRXHTC-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI792810A FI792810A (fi) | 1972-04-12 | 1979-09-10 | Kromonderivat |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3723572 | 1972-04-12 | ||
| JP47037235A JPS5118955B2 (un) | 1972-04-12 | 1972-04-12 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI57408B FI57408B (fi) | 1980-04-30 |
| FI57408C true FI57408C (fi) | 1980-08-11 |
Family
ID=12491931
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI1160/73A FI57408C (fi) | 1972-04-12 | 1973-04-12 | Foerfarande foer framstaellning av antiallergiska 3-(tetrazol-5-yl)-kromoner |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US3896114A (un) |
| JP (1) | JPS5118955B2 (un) |
| AT (1) | AT323739B (un) |
| AU (1) | AU470496B2 (un) |
| BE (1) | BE798059A (un) |
| CA (1) | CA1006160A (un) |
| CH (3) | CH582174A5 (un) |
| CS (2) | CS185620B2 (un) |
| DE (1) | DE2317899A1 (un) |
| ES (2) | ES413577A1 (un) |
| FI (1) | FI57408C (un) |
| FR (2) | FR2182951B1 (un) |
| GB (2) | GB1417462A (un) |
| HU (2) | HU168124B (un) |
| NL (1) | NL7305020A (un) |
| NO (2) | NO137825C (un) |
| PH (2) | PH13020A (un) |
| PL (1) | PL89172B1 (un) |
| SE (2) | SE402291B (un) |
| SU (2) | SU500758A3 (un) |
| ZA (1) | ZA732526B (un) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1540391A (en) * | 1975-04-11 | 1979-02-14 | Takeda Chemical Industries Ltd | 3-(1h-tetrazol-5-yl)-chromone derivatives |
| US4033845A (en) * | 1975-11-20 | 1977-07-05 | Warner-Lambert Company | [2-(4-Oxo-4H-1-benzopyran-2-yl)ethenyl]benzonitriles and benzoic acids |
| GB1560489A (en) * | 1976-05-21 | 1980-02-06 | Fisons Ltd | Pharmaceutical compositions |
| US4183945A (en) * | 1976-06-16 | 1980-01-15 | Carlo Erba S.P.A. | Substituted 2-vinyl-chromones and process for their preparation |
| US4177276A (en) * | 1976-06-16 | 1979-12-04 | Farmitalia Carlo Erba, S.P.A. | Substituted 2-vinyl-chromones and process for their preparation |
| AU508350B2 (en) * | 1976-06-16 | 1980-03-20 | Farmitalia Carlo Erba S.P.A. | Substicuted 2-vinyl-chromones |
| US4183946A (en) * | 1976-06-16 | 1980-01-15 | Carlo Erba S.P.A. | Substituted 2-vinyl-chromones and process for their preparation |
| US4143145A (en) * | 1977-01-12 | 1979-03-06 | Carlo Erba S. P. A. | Substituted 2-vinyl-chromones and process for their preparation |
| US4116971A (en) * | 1977-08-15 | 1978-09-26 | Warner-Lambert Company | 3-(1h-tetrazol-5-yl)chromones |
| US4360527A (en) * | 1977-10-13 | 1982-11-23 | Warner-Lambert Company | 9-(Hydroxy, lower alkoxy or lower alkanoyloxy)-2-(1H-tetrazol-5-yl)naphtho-(2,1-b)-pyran-1-ones and anti-allergic use thereof |
| DE2840936C2 (de) * | 1978-09-20 | 1983-02-10 | Warner-Lambert Co., 07950 Morris Plains, N.J. | 3-(1H-Tetrazol-5-yl)-chromone und ihre Verwendung |
| ATE14579T1 (de) * | 1979-03-20 | 1985-08-15 | Fisons Plc | Pharmazeutische heterocyclische verbindungen, verfahren zu ihrer herstellung und sie enthaltende zusammensetzungen. |
| ZA804788B (en) * | 1979-10-26 | 1981-07-29 | Erba Farmitalia | Substituted 2-(pyridyl-cyclopropyl)-chromones and process for their preparation |
| JP2004323392A (ja) * | 2003-04-23 | 2004-11-18 | Toyo Kasei Kogyo Co Ltd | ビテトラゾールアミン化合物の製造方法 |
| GB201506572D0 (en) | 2015-04-17 | 2015-06-03 | Johnson Matthey Davy Technologies Ltd | Process |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA960223A (en) * | 1970-02-05 | 1974-12-31 | Mervyn E. Peel | Tetrazolyl chromones |
-
1972
- 1972-04-12 JP JP47037235A patent/JPS5118955B2/ja not_active Expired
-
1973
- 1973-04-05 AU AU54132/73A patent/AU470496B2/en not_active Expired
- 1973-04-10 NL NL7305020A patent/NL7305020A/xx not_active Application Discontinuation
- 1973-04-10 DE DE2317899A patent/DE2317899A1/de not_active Withdrawn
- 1973-04-10 FR FR7312922A patent/FR2182951B1/fr not_active Expired
- 1973-04-10 US US349848A patent/US3896114A/en not_active Expired - Lifetime
- 1973-04-10 PL PL1973161818A patent/PL89172B1/pl unknown
- 1973-04-11 SU SU1913752A patent/SU500758A3/ru active
- 1973-04-11 ES ES413577A patent/ES413577A1/es not_active Expired
- 1973-04-11 CS CS7300002571A patent/CS185620B2/cs unknown
- 1973-04-11 PH PH14507A patent/PH13020A/en unknown
- 1973-04-11 SE SE7305124A patent/SE402291B/xx unknown
- 1973-04-11 NO NO1505/73A patent/NO137825C/no unknown
- 1973-04-11 CA CA168,432A patent/CA1006160A/en not_active Expired
- 1973-04-11 CS CS7500001198A patent/CS185639B2/cs unknown
- 1973-04-11 BE BE129880A patent/BE798059A/xx unknown
- 1973-04-12 FI FI1160/73A patent/FI57408C/fi active
- 1973-04-12 CH CH523773A patent/CH582174A5/xx not_active IP Right Cessation
- 1973-04-12 CH CH127977A patent/CH605891A5/xx not_active IP Right Cessation
- 1973-04-12 HU HUTA1333A patent/HU168124B/hu unknown
- 1973-04-12 GB GB1497275A patent/GB1417462A/en not_active Expired
- 1973-04-12 ZA ZA732526A patent/ZA732526B/xx unknown
- 1973-04-12 HU HUTA1246A patent/HU167386B/hu unknown
- 1973-04-12 CH CH921976A patent/CH603616A5/xx not_active IP Right Cessation
- 1973-04-12 GB GB1760273A patent/GB1417461A/en not_active Expired
- 1973-04-12 AT AT325073A patent/AT323739B/de not_active IP Right Cessation
-
1974
- 1974-10-11 NO NO743670A patent/NO141556C/no unknown
- 1974-12-19 ES ES0433109A patent/ES433109A1/es not_active Expired
-
1975
- 1975-01-17 SU SU752099318A patent/SU745367A3/ru active
- 1975-04-10 FR FR7511248A patent/FR2273003B1/fr not_active Expired
-
1976
- 1976-02-18 SE SE7601868A patent/SE7601868L/xx unknown
-
1977
- 1977-07-21 PH PH20019A patent/PH13114A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI57408C (fi) | Foerfarande foer framstaellning av antiallergiska 3-(tetrazol-5-yl)-kromoner | |
| EP0747368B1 (en) | Derivatives of monocyclic polyamines, their preparation, and their use as antiviral agents | |
| JPH0559118B2 (un) | ||
| JPH0366311B2 (un) | ||
| JPH0224821B2 (un) | ||
| EA020681B1 (ru) | Циклические n,n'-диарилтиомочевины и n,n'-диарилмочевины - антагонисты андрогеновых рецепторов, противораковое средство, способ получения и применения | |
| IE920409A1 (en) | Complexing agents | |
| US4066650A (en) | Keto-aldehyde-amine addition products and method of making same | |
| DE4304650A1 (de) | Kondensierte 5-gliedrige Heterocyclen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| FI77864C (fi) | Foerfarande foer framstaellning av ett nytt, terapeutiskt anvaendbart 7-piperidino-1,2,3,5-tetrahydroimidazo /2,1-b/kinazolin-2-on. | |
| KR900003368B1 (ko) | 신규한 인데노티아졸 유도체의 제조방법 | |
| CS252461B2 (en) | Method of 2-guanidino-4-(2-subst.-amino-4-imidazolyl)thiazoles production | |
| WO2020232332A1 (en) | Pyrrolopyrimidine inhibitors of wild-type and mutant forms of lrrk2 | |
| AU600378B2 (en) | Piperidine derivatives, their preparation and their application in therapy | |
| WO2020233289A1 (zh) | 托拉塞米磷酸酯类前药、其制备方法及组合物 | |
| EP0040422B1 (en) | Novel substituted pyrazinyl-1,2,4-oxadiazoles, processes for preparing the same and a pharmaceutical composition containing the same | |
| US4857536A (en) | Antihistaminic benzimidazole derivatives | |
| EP2692724A1 (en) | Chiral 3-hydroxypyrid-4-one derivative, and synthesis and use thereof | |
| DE2117657A1 (en) | Amino-subst pyrido(3,2-d)pyrimidines - useful for inhibiting thrombocyte aggregation and adhesion | |
| WO2015091827A1 (en) | Bendamustine derivatives and related compounds | |
| US4418062A (en) | Amino derivatives of chloro nitro amino pyrazines useful as adjuncts to radiation therapy | |
| JP3032844B2 (ja) | ピリミジンジオン誘導体 | |
| AU732722B2 (en) | 2-{4-{4-(4,5-dichloro-2- methylimidazol-1-yl)butyl} -1-piperazinyl}-5-fluoropyrimidine, its preparation and its therapeutic use | |
| EP0641784B1 (en) | Benzimidazole derivative, production thereof, antiemetic containing same as active ingredient, and intermediate for producing same | |
| KR100307660B1 (ko) | 도파민재소비저해제 |